Labceutics to Conduct Pan European Quality Assurance Study on Standardization of BCR-ABL1 Testing to Improve Patient Management in CML BELFAST, UNITED KINGDOM--(Marketwire - Mar 12, 2013) - Labceutics Inc. announced today that it has partnered with Asuragen Inc., a leading molecular diagnostics company, to conduct an international...